Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Ets-1 is associated with cancer progression and metastasis in many types of cancer.
|
31072446 |
2019 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Typically, Ets-1 activity is low in healthy cells, but elevated levels of expression have been found in cancerous cells, specifically related to tumor progression.
|
30019773 |
2018 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
MicroRNA‑874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.
|
30106442 |
2018 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Overexpression of erythroblastosis virus E26 oncogene homolog 1 (ETS1) gene is correlated with both tumor progression and poor response to chemotherapy in cancer treatment, and the exploitation of RNA interference (RNAi) technology to downregulate ETS1 seems to be a promising approach to reverse multidrug-resistant cancer cells to chemotherapy.
|
28302581 |
2017 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Ets1 belongs to the large family of the ETS domain family of transcription factors and is involved in cancer progression.
|
26392377 |
2015 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The transcription factor E26 transformation specific-1 (ETS1) is believed to be intimately involved in tumor progression, and is frequently upregulated in tumors, including ccRCC.
|
25776481 |
2015 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Ets-1 is a transcription factor that regulates many genes involved in cancer progression and in tumour invasion.
|
23405229 |
2013 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
The Ets-1 transcription factor is a candidate breast cancer oncogene that regulates the expression of genes involved in tumor progression and metastasis.
|
22971289 |
2012 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
With regard to the involvement of some ETS transcription factors, especially Ets-1, in malignant transformation and tumour progression (including invasion, metastasis and neoangiogenesis) through transactivation of cancer related genes, they are potential molecular targets for selective cancer therapy.
|
18855726 |
2008 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
The ETS transcription factor Ets-1 (E26 transformation-specific-1) plays a critical role in many physiological processes including angiogenesis, haematopoietic development and tumour progression.
|
17456046 |
2007 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
The aim of this study was to investigate the expression of Ets-1 in a large panel of human breast cancers and relate its levels to the parameters of tumour progression and metastasis.
|
15365563 |
2004 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
These findings suggest that Ets-1 expression is related to the carcinogenesis of human pancreatic carcinoma, but its relationship to tumor progression is unclear.
|
9504693 |
1998 |